Raphael Pharmaceutical Inc. (RAPH) Operating income 2020–2025
Raphael Pharmaceutical Inc. (RAPH) annual operating income history from SEC filings — each fiscal year as reported.
-$1.2MFY2025 · since FY2020: -$706,000 → -$1.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.2M | +17.5% |
| FY2024 | -$1.5M | -13.3% |
| FY2023 | -$1.3M | +59.8% |
| FY2022 | -$3.3M | -103.6% |
| FY2021 | -$1.6M | -130.7% |
| FY2020 | -$706,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice